Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Unicycive Therapeutics, Inc. - Common Stock
(NQ:
UNCY
)
5.210
-0.050 (-0.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Unicycive Therapeutics, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series
August 29, 2023
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
Where Unicycive Therapeutics Stands With Analysts
↗
August 16, 2023
Via
Benzinga
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
August 14, 2023
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
July 21, 2023
Via
ACCESSWIRE
Analyst Expectations for Unicycive Therapeutics's Future
↗
July 19, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Unicycive Therapeutics
↗
June 26, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Unicycive Therapeutics
↗
May 17, 2023
Via
Benzinga
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
July 21, 2023
Via
ACCESSWIRE
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference
July 20, 2023
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology
July 18, 2023
Newly Assigned USAN Name, Oxylanthanum Carbonate, replaces Lanthanum Dioxycarbonate
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
Analyst Expectations for Unicycive Therapeutics's Future
↗
May 17, 2023
Via
Benzinga
Expert Ratings for Unicycive Therapeutics
↗
March 31, 2023
Via
Benzinga
Nasdaq Jumps 200 Points; Baudax Bio Shares Spike Higher
↗
June 30, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded up 0.93% to 34,439.75 while the NASDAQ rose 1.54% to 13,800.92. The S&P 500,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
June 30, 2023
Via
Benzinga
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
June 30, 2023
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top...
Via
Benzinga
Crude Oil Rises Over 1%; Fed's Preferred Inflation Gauge Slows In May
↗
June 30, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.62% to 34,333.42 while the NASDAQ rose 1.37% to 13,777.52. The S&P 500,...
Via
Benzinga
Why Is Enphase Energy (ENPH) Stock Up Today?
↗
June 30, 2023
Enphase Energy (ENPH) stock is on the rise Friday as investors react to the company expanding its distribution partnership in Europe.
Via
InvestorPlace
XPEV Stock Alert: Xpeng’s SUV Pricing Beats Out Tesla’s Model Y
↗
June 30, 2023
Xpeng (XPEV) stock is rallying higher on Friday after the electric vehicle (EV) company priced its G6 SUV below Tesla's (TSLA) Model Y.
Via
InvestorPlace
Why Is Unicycive Therapeutics (UNCY) Down 24% Today?
↗
June 30, 2023
Unicycive Therapeutics (UNCY) stock is falling on Friday after the medical company provided investors with an update from regulators.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
June 30, 2023
Via
Benzinga
Why Are Unicycive Therapeutics Shares Trading Lower Today
↗
June 30, 2023
Unicycive Therapeutics Inc (NASDAQ: UNCY) provided an update based on recent interactions with the FDA concerning the company's New Drug Application (NDA) for lanthanum dioxycarbonate (LDC),
Via
Benzinga
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
↗
June 30, 2023
Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
June 30, 2023
It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today!
Via
InvestorPlace
Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program
June 29, 2023
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
Unicycive to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
June 16, 2023
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
Unicycive Therapeutics, Inc. and Alarum Technologies Ltd. Interviews to Air on Bloomberg TV on the RedChip Money Report®
June 09, 2023
Via
ACCESSWIRE
Unicycive Announces First Quarter 2023 Financial Results and Provides Business Update
May 16, 2023
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress
April 24, 2023
Data highlights the potential safety and reno-protective effect of UNI-494
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
10 Short Squeeze Candidates: Getty Images Tops List, PaxMedica Rejoins Top Five, MicroStrategy Moves Up And More
↗
April 10, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2023 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...
Via
Benzinga
5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More
↗
April 03, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
